170 related articles for article (PubMed ID: 37453564)
21. Advances in small bowel neuroendocrine neoplasia.
Banck MS; Beutler AS
Curr Opin Gastroenterol; 2014 Mar; 30(2):163-7. PubMed ID: 24441281
[TBL] [Abstract][Full Text] [Related]
22. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
Snorradottir S; Asgeirsdottir A; Rögnvaldsson S; Jonasson JG; Björnsson ES
Cancer Epidemiol; 2022 Aug; 79():102197. PubMed ID: 35716441
[TBL] [Abstract][Full Text] [Related]
23. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
[TBL] [Abstract][Full Text] [Related]
24. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
25. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/β-catenin signaling.
Carmon KS; Lin Q; Gong X; Thomas A; Liu Q
Mol Cell Biol; 2012 Jun; 32(11):2054-64. PubMed ID: 22473993
[TBL] [Abstract][Full Text] [Related]
26. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Basim Ibrahim I; Hedenström P; Valente R; Hayes AJ; Siuka D; Gladhaug IP; Capurso G
Scand J Gastroenterol; 2017 Aug; 52(8):797-802. PubMed ID: 28394712
[TBL] [Abstract][Full Text] [Related]
27. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome.
Tyrmi JS; Arffman RK; Pujol-Gualdo N; Kurra V; Morin-Papunen L; Sliz E; ; Piltonen TT; Laisk T; Kettunen J; Laivuori H
Hum Reprod; 2022 Jan; 37(2):352-365. PubMed ID: 34791234
[TBL] [Abstract][Full Text] [Related]
28. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
29. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
30. Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors.
Kidd M; Modlin IM; Drozdov I
BMC Genomics; 2014 Jul; 15(1):595. PubMed ID: 25023465
[TBL] [Abstract][Full Text] [Related]
31. LGR5 constitutively activates NF-κB signaling to regulate the growth of intestinal crypts.
Lai S; Cheng R; Gao D; Chen YG; Deng C
FASEB J; 2020 Nov; 34(11):15605-15620. PubMed ID: 33001511
[TBL] [Abstract][Full Text] [Related]
32. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
[TBL] [Abstract][Full Text] [Related]
33. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.
Li SC; Khan M; Caplin M; Meyer T; Öberg K; Giandomenico V
PLoS One; 2015; 10(5):e0125553. PubMed ID: 25942502
[TBL] [Abstract][Full Text] [Related]
35. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal carcinomatosis from small intestinal neuroendocrine tumors: Clinical course and genetic profiling.
Norlén O; Edfeldt K; Akerstrom G; Westin G; Hellman P; Bjorklund P; Stalberg P
Surgery; 2014 Dec; 156(6):1512-21; discussion 1521-2. PubMed ID: 25456945
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant
Fotouhi O; Ghaderi M; Wang N; Zedenius J; Kjellman M; Xu D; Juhlin CC; Larsson C
Epigenetics; 2019 Dec; 14(12):1224-1233. PubMed ID: 31322481
[TBL] [Abstract][Full Text] [Related]
38. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
39. Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.
Andersson E; Arvidsson Y; Swärd C; Hofving T; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2016 Jun; 29(6):616-29. PubMed ID: 26965582
[TBL] [Abstract][Full Text] [Related]
40. Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
Gao F; Zafar MI; Jüttner S; Höcker M; Wiedenmann B
Med Sci Monit; 2018 Nov; 24():8125-8140. PubMed ID: 30420588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
